GlassScriptPhysician profile
Neha Patel
NPI 1184921421
$1,224.83
in general payments reported to CMS, 2019-2025
9 companies · $186 in 2025
The $186 reported for 2025 was less than what a typical Allergy & Immunology (Internal Medicine) provider received nationally (typical 2025 total: $681).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.28 · 2022: $144 · 2023: $497 · 2024: $309 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $893 · Education: $99.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $892.97 |
| Education | $99.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $380.68 | 2022-2024 | Amplatzer Amulet, Cardiomems, Optis |
| Boston Scientific Corporation | $288.67 | 2023-2024 | Watchman Flx, Watchman Access System |
| Medtronic, INC. | $105.17 | 2023-2024 | Cobalt Dr Mri Surescan |
| Philips North America LLC | $102.37 | 2025 | Eagle Eye |
| Regeneron Healthcare Solutions, INC. | $99.22 | 2023 | Dupixent |
| Glaxosmithkline, LLC. | $88.28 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $83.61 | 2025 | Wainua |
| Davol INC. | $56.76 | 2023-2024 | Arista Ah Flexitip |
| Bausch & Lomb Americas INC. | $20.07 | 2024 | Vyzulta, Miebo, Lotemax Sm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neha Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.